You are here: Home 
Categories Investigative Urology
Categories Investigative Urology Genome abnormalities precede prostate cancer and predict clinical relapse - Abstract
Genome abnormalities precede prostate cancer and predict clinical relapse - Abstract
Published on 08 August 2012
The prediction of prostate cancer clinical outcome remains a major challenge after the diagnosis, even with improved early detection by prostate-specific antigen (PSA) monitoring.
To read more, a FREE Urotoday registration is required. Click here to register or login above.To read UIJ content, a separate subscription is required.
Tags: